// THE GROWTH CHAIR

You Can't Sell a Platform

What Lotus, Apertio, Intuwave and Lumeon taught me about winning markets.

Illustration for the essay: You Can't Sell a Platform

Most platform companies don’t fail because the technology is weak. They fail because they try to do too much, too early, for too many people.

No one buys a platform. They buy a solution to a problem they care about.

I’ve seen this pattern repeat across multiple companies.

At Lotus, Notes eventually became incredibly sticky. Entire organisations ran critical workflows on it. But it took a long time to get there. Early on, it tried to be everything: database, email, applications. It struggled to land. What worked wasn’t the platform story. It was very specific use cases, document workflows, approvals, regulatory processes, where partners could build practical applications that solved real problems. That’s where adoption came from.

At Intuwave, I was brought in to fix the classic mistake. The team had built a mobile platform and tried to sell it as a platform. It went nowhere. The turnaround came from focusing on one tangible problem: helping mobile operators support devices remotely. Suddenly there was a buyer, a budget, and urgency. Same technology. Different outcome.

Apertio got it right from the start. We focused relentlessly on one problem: replacing legacy home location register infrastructure in mobile networks. It was a massive, expensive, visible pain point. We solved it better than anyone else. That focus drove scale, credibility, and ultimately an acquisition. The broader platform capabilities came later, once we had earned the right.

At Lumeon, I watched this tension up close. The platform orchestrates complex healthcare workflows at scale across patients, clinicians and systems. The harder question is the one every platform company eventually faces: which single use case to own first. That decision is what separates a capable platform from a category winner. It’s also one of the hardest calls a founder or CEO ever makes.

This is the uncomfortable truth. Focus feels like constraint, especially to founders. Most entrepreneurial CEOs are wired to solve problems. New problems are interesting. Repeating the same solution in the same market is not. So they add features, expand use cases, chase adjacent opportunities too early. That instinct is often what kills the business.

The discipline required to win a market is boring. It’s repetition. It’s saying no. It’s doubling down on the same problem until you are unquestionably the best at solving it. Only then does the platform matter.

The pattern is simple. Pick a target market where the pain is real and urgent. Build a solution that clearly beats alternatives. Drive adoption until you have momentum and credibility. Then expand carefully into adjacent areas.

Do it in any other order, and you’re just another platform looking for a problem.

// Originally published on The Growth Chair · 23 Apr 2026 · Join the discussion on Substack

// THE GROWTH CHAIR BY EMAIL

One essay like this every week. Free. No paywall.

Delivered via Substack. Unsubscribe any time. See our privacy notice.

// GET IN TOUCH

Clarity when it counts.

If you have a board seat, a fractional mandate or a commercial reset coming up in the next 90 days, email directly. We'll book 30 minutes to see whether Ortent is the right fit.

Book a 30-minute intro call